Abstract:Background: We investigated for the first time the proteomic profiles both in the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC) of major depressive disorder (MDD) and bipolar disorder (BD) patients.Methods: Cryostat sections of DLPFC and ACC of MDD and BD patients with their respective well-matched controls were used for study. Proteins were quantified by tandem mass tag and high-performance liquid chromatography-mass spectrometry system, Gene Ontology terms and functional cluster alteration were analyzed through bioinformatic analysis.Findings: Over 3000 proteins were accurately quantified, with more than 100 protein expression identified as significantly changed in these two brain areas of MDD and BD patients as compared to their respective controls, including OGDH, SUCLG1 and COX5B in DLPFC in MDD patients; PFN1, RDX and PDCD6IP in ACC of MDD patients; DBN1, DBNL and MYH9 in DLPFC in BD patients. Impressively, depending on brain area and subtype of disease, the most notable change we found in the DLPFC of MDD was ‘suppressed energy metabolism’, in the ACC of MDD it was ‘suppressed tissue remodeling and suppressed immune response’, and in the DLPFC of BD it was differentiated ‘suppressed tissue remodeling and suppressed neuronal projection’.Interpretation: In summary, there are distinct proteomic changes in different brain areas of the same mood disorder, and in the same brain area between MDD and BD patients, which strengthens the distinct pathogeneses and thus treatment targets.Funding Information: This study was supported by the National Key R&D Program of China (2016YFC1306700) and the National Natural Science Foundation of China (81971268).Declaration of Interests: There are no financial or other relationships that might lead to a conflict of interest.Ethics Approval Statement: All the brain material is obtained from the Netherlands Brain Bank (NBB) using well standardized protocols with written informed consent obtained by the NBB for a brain autopsy and for the use of the material and clinical information for research purposes.

Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients.

Prefrontal Alterations in GABAergic and Glutamatergic Gene Expression in Relation to Depression and Suicide.

Changes in glial gene expression in the prefrontal cortex in relation to major depressive disorder, suicide and psychotic features

Increased Glutamic Acid Decarboxylase Expression in the Hypothalamic Suprachiasmatic Nucleus in Depression

Neurometabolic Characteristics in the Anterior Cingulate Gyrus of Alzheimer’s Disease Patients with Depression: a 1H Magnetic Resonance Spectroscopy Study

Prefrontal changes in the glutamate-glutamine cycle and neuronal/glial glutamate transporters in depression with and without suicide

Aberrant Stress Hormone Receptor Balance in the Human Prefrontal Cortex and Hypothalamic Paraventricular Nucleus of Depressed Patients.

Distinct proteomic profiles in prefrontal subareas of elderly major depressive disorder and bipolar disorder patients

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Peripheral Upregulation of Parkinson's Disease-Associated Genes Encoding α-Synuclein, β-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression

Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide

Dissociation of Glutamate and Cortical Thickness is Restricted to Regions Subserving Trait but Not State Markers in Major Depressive Disorder

Evidence of decreased gap junction coupling between astrocytes and oligodendrocytes in the anterior cingulate cortex of depressed suicides

Lower Levels of GABAergic Function Markers in Corticotropin-Releasing Hormone-Expressing Neurons in the sgACC of Human Subjects With Depression

Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: a postmortem study.

Gene Expression Analysis of Multiple Brain Regions in Major Depressive Disorder

Distinct Proteomic Profiles in Prefrontal Subareas of Major Depressive Disorder and Bipolar Disorder Patients

Alterations in CRY2 and PER3 gene expression associated with thalamic-limbic community structural abnormalities in patients with bipolar depression or unipolar depression

T21. ALTERATIONS OF CRY2 AND PER3 GENE EXPRESSION ARE ASSOCIATED WITH GRAY MATTER ABNORMALITIES OF THALAMIC-LIMBIC NETWORK IN UNIPOLAR DEPRESSION AND BIPOLAR DEPRESSION

A Combined Analysis of Genome-Wide Expression Profiling of Bipolar Disorder in Human Prefrontal Cortex.